Bird & Bird has advised Gaussion. Osborne Clarke has acted for AlbionVC and UCL Technology Fund Gaussion has completed a $28 million funding round, bringing its...
Gaussion Secures $28 Million in Funding to Accelerate Battery Innovation
Bloomsbury Genetic Therapies Limited’s £5 Million Seed Financing
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...


























